SUPREMEINFNSESupreme Infrastructure India Limited· ConstructionHighNeutral
Announced Thu, 14 Aug · 21:29 IST

Supreme Infrastructure India Limited has informed the Exchange regarding 'Unaudited Financial Result for the Quarter ended June 30, 2025'.

Going ConcernQualified OpinionEmphasis Of MatterRevenue DeclinePat NegativeExceptional ItemResults View source PDF

SUPREMEINF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Supreme Infrastructure India reported deeply weak Q1 FY26 results, with standalone revenue from operations collapsing to ₹832.30 lakhs from ₹2,666.37 lakhs in Q1 FY25, a drop of about 69%. The company posted a standalone net loss of ₹39,989.13 lakhs (consolidated loss ₹39,990.55 lakhs), taking accumulated losses to roughly ₹7,19,053 lakhs and fully eroding net worth. The statutory auditor (Borkar & Muzumdar) issued a Modified Review Conclusion on both standalone and consolidated results, flagging issues around long-pending trade receivables of ₹75,814.87 lakhs, investments and dues of ₹142,556.84 lakhs stuck in erstwhile subsidiary SIBPL (under CIRP since May 2024), and ₹15,677 lakhs plus related dues tied to SPITPL (under CIRP since August 2024). The auditor also explicitly highlighted a Material Uncertainty Related to Going Concern, noting defaults in loan repayments. Management is relying on a Scheme of Arrangement approved by NCLT Mumbai on March 28, 2025, and a fresh equity/warrant allotment completed on July 3, 2025 to continue on a going-concern basis.

Likely market impact

This is a deeply negative filing for shareholders. Operations have shrunk sharply, the company is loss-making with fully eroded net worth, two subsidiaries are in insolvency, and the auditor has flagged going-concern doubt — meaning there is real risk the company may not survive as a going concern without successful execution of the NCLT-approved scheme and equity infusion. Equity holders face significant dilution risk and the stock is likely to remain under severe pressure.